KALA BIO, Inc.
For the period ended Mar 31, 2026. Filed May 15, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 15, 2026
KALA$0.18+13.7%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
Exhibit Index
| | | |
|---|---|---|
| EXHIBIT 3.1 | | Certificate of Amendment to Restated Certificate of Incorporation, as amended, of KALA BIO, Inc. (incorporated by reference to Exhibit 3.2 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 2, 2026) |
| | | |
| EXHIBIT 3.2 | | Certificate of Amendment to the Restated Certificate of Incorporation, as amended, of KALA BIO, Inc (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 7, 2026) |
| | | |
| EXHIBIT 3.3 | | Certificate of Designations, Preferences and Rights of Series AAA Convertible Non-Redeemable Preferred Stock of KALA BIO, Inc. (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 2, 2026) |
| | | |
| EXHIBIT 10.1 | | At the Market Offering Agreement, dated as of January 8, 2026, by and between the Company and H.C. Wainwright & Co., LLC (incorporated by reference to Exhibit 1.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on January 8, 2026) |
| | | |
| EXHIBIT 10.2 | | Form of Securities Purchase Agreement, dated as of January 30, 2026, by and among the Company and each of the Series AAA Investors signatory thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 2, 2026) |
| | | |
| EXHIBIT 10.3 | | Platform Development and Exclusive License Agreement, dated March 3, 2026 (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission on March 4, 2026) |
| | | |
| EXHIBIT 10.4 | | Secured Promissory Note, dated as of February 9, 2026, by and between the Company and Minglemint Solutions LLC (incorporated by reference to Exhibit 10.48 to the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 15, 2026) |
| | | |
| EXHIBIT 10.5 | | Security Agreement, dated February 9, 2026, by and between the Company and Minglemint Solutions LLC (incorporated by reference to Exhibit 10.49 to the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 15, 2026) |
| | | |
| EXHIBIT 10.6+ | | Note Amending Agreement, dated as of May 11, 2026, by and between the Company and Minglemint Solutions LLC |
| | | |
| EXHIBIT 31.1+ | - | Certification of Chief Executive Officer pursuant to Rules 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| | ||
| EXHIBIT 31.2+ | - | Certification of Chief Financial Officer pursuant to Rules 13a-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| | ||
| EXHIBIT 32.1++ | - | Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of The Sarbanes-Oxley Act of 2002, by Avi Minkowitz Chief Executive Officer. |
| | | |
| EXHIBIT 32.2++ | - | Certifications pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of The Sarbanes-Oxley Act of 2002, by Avi Minkowitz, Chief Financial Officer of the Company. |
| | ||
| EXHIBIT 101.INS | - | Inline XBRL Instance Document. (the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document) |
|---|---|---|
| | | |
| EXHIBIT 101.SCH | - | Inline XBRL Taxonomy Extension Schema Document. |
| | | |
| EXHIBIT 101.CAL | - | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| | | |
| EXHIBIT 101.DEF | - | Inline XBRL Taxonomy Extension Definition Linkbase Document. |
| | | |
| EXHIBIT 101.LAB | - | Inline XBRL Taxonomy Extension Label Linkbase Document. |
| | | |
| EXHIBIT 101.PRE | - | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
| | | |
| EXHIBIT 104 | - | Cover Page Interactive Data File (formatted as Inline XBRL with applicable taxonomy extension information contained in Exhibits 101). |
- Filed herewith
++ Furnished herewith
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.